| [1] |
Zhang D, Yang X, Yang Z, et al. Daughter cells and erythroid cells budding from PGCCs and their clinicopathological significances in colorectal cancer[J]. J Cancer, 2017, 8(3): 469-478. DOI: 10.7150/jca.17012.
doi: 10.7150/jca.17012
pmid: 28261349
|
| [2] |
Fei F, Zhang D, Yang Z, et al. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer[J]. J Exp Clin Cancer Res, 2015, 34: 158. DOI: 10.1186/s13046-015-0277-8.
doi: 10.1186/s13046-015-0277-8
|
| [3] |
Qu Y, Zhang L, Rong Z, et al. Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma[J]. J Exp Clin Cancer Res, 2013, 32(1): 75. DOI: 10.1186/1756-9966-32-75.
doi: 10.1186/1756-9966-32-75
|
| [4] |
Zhang S, Mercado-Uribe I, Hanash S, et al. iTRAQ-based proteomic analysis of polyploid giant cancer cells and budding progeny cells reveals several distinct pathways for ovarian cancer development[J]. PLoS One, 2013, 8(11): e80120. DOI: 10.1371/journal.pone.0080120.
doi: 10.1371/journal.pone.0080120
|
| [5] |
Richards JS, Candelaria NR, Lanz RB. Polyploid giant cancer cells and ovarian cancer: new insights into mitotic regulators and polyploidy[J]. Biol Reprod, 2021, 105(2): 305-316. DOI: 10.1093/biolre/ioab102.
doi: 10.1093/biolre/ioab102
|
| [6] |
Nehme Z, Pasquereau S, Haidar Ahmad S, et al. Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus[J]. Oncogene, 2021, 40(17): 3030-3046. DOI: 10.1038/s41388-021-01715-7.
doi: 10.1038/s41388-021-01715-7
|
| [7] |
Herbein G, Nehme Z. Polyploid giant cancer cells, a hallmark of oncoviruses and a new therapeutic challenge[J]. Front Oncol, 2020, 10: 567116. DOI: 10.3389/fonc.2020.567116.
doi: 10.3389/fonc.2020.567116
|
| [8] |
Kudo-Saito C, Miyamoto T, Imazeki H, et al. IL33 is a key driver of treatment resistance of cancer[J]. Cancer Res, 2020, 80(10): 1981-1990. DOI: 10.1158/0008-5472.CAN-19-2235.
doi: 10.1158/0008-5472.CAN-19-2235
pmid: 32156776
|
| [9] |
Liu K, Lu R, Zhao Q, et al. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation[J]. Med Oncol, 2019, 37(1): 6. DOI: 10.1007/s12032-019-1330-9.
doi: 10.1007/s12032-019-1330-9
|
| [10] |
Fei F, Zhang M, Li B, et al. Formation of polyploid giant cancer cells involves in the prognostic value of neoadjuvant chemoradiation in locally advanced rectal cancer[J]. J Oncol, 2019, 2019: 2316436. DOI: 10.1155/2019/2316436.
doi: 10.1155/2019/2316436
|
| [11] |
White-Gilbertson S, Lu P, Norris JS, et al. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis[J]. J Lipid Res, 2019, 60(7): 1225-1235. DOI: 10.1194/jlr.M092247.
doi: 10.1194/jlr.M092247
pmid: 30988134
|
| [12] |
White-Gilbertson S, Lu P, Jones CM, et al. Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis[J]. Cancer Med, 2020, 9(9): 3142-3152. DOI: 10.1002/cam4.2960.
doi: 10.1002/cam4.2960
|
| [13] |
Zhang Z, Feng X, Deng Z, et al. Irradiation-induced polyploid giant cancer cells are involved in tumor cell repopulation via neosis[J]. Mol Oncol, 2021, 15(8): 2219-2234. DOI: 10.1002/1878-0261.12913.
doi: 10.1002/1878-0261.12913
|
| [14] |
Salmina K, Huna A, Kalejs M, et al. The cancer aneuploidy paradox: in the light of evolution[J]. Genes (Basel), 2019, 10(2): 83. DOI: 10.3390/genes10020083.
doi: 10.3390/genes10020083
|
| [15] |
Mirzayans R, Andrais B, Murray D. Roles of polyploid/multinu-cleated giant cancer cells in metastasis and disease relapse following anticancer treatment[J]. Cancers (Basel), 2018, 10(4): 118. DOI: 10.3390/cancers10040118.
doi: 10.3390/cancers10040118
|
| [16] |
Mirzayans R, Andrais B, Scott A, et al. Multinucleated giant cancer cells produced in response to ionizing radiation retain viability and replicate their genome[J]. Int J Mol Sci, 2017, 18(2): 360. DOI: 10.3390/ijms18020360.
doi: 10.3390/ijms18020360
|
| [17] |
Zhang S, Mercado-Uribe I, Liu J. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel[J]. Int J Cancer, 2014, 134(3): 508-518. DOI: 10.1002/ijc.28319.
doi: 10.1002/ijc.28319
|
| [18] |
Chen J, Niu N, Zhang J, et al. Polyploid giant cancer cells (PGCCs): the evil roots of cancer[J]. Curr Cancer Drug Targets, 2019, 19(5): 360-367. DOI: 10.2174/1568009618666180703154233.
doi: 10.2174/1568009618666180703154233
|
| [19] |
Saleh T, Carpenter VJ, Bloukh S, et al. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies[J]. Semin Cancer Biol, 2022, 81: 37-47. DOI: 10.1016/j.semcancer.2020.12.010.
doi: 10.1016/j.semcancer.2020.12.010
|
| [20] |
王丽丽, 赵松, 欧阳明玥, 等. 多西他赛诱导的多倍体肿瘤细胞在肿瘤复发中的作用[J]. 国际肿瘤学杂志, 2020, 47(6): 340-345. DOI: 10.3760/cma.j.cn371439-20200103-00032.
doi: 10.3760/cma.j.cn371439-20200103-00032
|
| [21] |
王丽丽, 欧阳明玥, 赵松, 等. 多西紫杉醇诱导的多倍体非小细胞肺癌A549细胞增殖及凋亡特性研究[J]. 肿瘤研究与临床, 2020, 32(9): 606-612. DOI: 10.3760/cma.j.cn115355-20191209-00565.
doi: 10.3760/cma.j.cn115355-20191209-00565
|
| [22] |
Niu N, Zhang J, Zhang N, et al. Linking genomic reorganization to tumor initiation via the giant cell cycle[J]. Oncogenesis, 2016, 5(12): e281. DOI: 10.1038/oncsis.2016.75.
doi: 10.1038/oncsis.2016.75
|
| [23] |
Park SY, Lee CJ, Choi JH, et al. The JAK2/STAT3/CCND2 axis promotes colorectal cancer stem cell persistence and radioresistance[J]. J Exp Clin Cancer Res, 2019, 38(1): 399. DOI: 10.1186/s13046-019-1405-7.
doi: 10.1186/s13046-019-1405-7
|